Stay updated on ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.

Latest updates to the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference1%
- Check17 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedVersion tag updated to v3.0.2 and the Back to Top element removed. This is a minor update with no substantive changes to core content, pricing, or availability.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of new drug information for Danicopan and Remdesivir, as well as a focus on Post-COVID Conditions and drug safety. However, specific location details and some drug categories have been removed.SummaryDifference2%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.